Navigation Links
Civil Rights and Medical Leaders Call for Social Justice in Health Care
Date:9/27/2007

said. "But encouragingly, we have witnessed a positive trend in heart health in America. Between 1994 and 2004 the death rate from coronary artery disease has declined by 33 percent. Kudos for medical science. Unfortunately, African Americans have not enjoyed the same benefit of this science. The cardiovascular death rate in Blacks dropped by only 11 percent. African Americans have twice the incidence of first stroke. And if you're a Black male, you can expect to live 13 years less than a White female." The explanation for the disparity in cardiovascular health is complex. Black Americans are diagnosed at a younger age and, when diagnosed, are more progressed, and mortality is higher. The causes of chronic heart failure in Blacks differ from the causes in Whites. During the past 25 years, Dr. DeVaughn noted, African Americans have benefited, but to a lesser degree, from advancements in treatments for congestive heart failure.

"It should be clear to even the non-medical observer than a unique solution is called for," said Dr. DeVaughn. "A race neutral approach to this entity has not worked, and has been responsible for thousands and thousands of unnecessary deaths."

Dr. Ofili, Dr. Williams, and Dr. DeVaughn, decried the appalling lack of support for adoption of BiDil, the scientifically-proven therapy that, in clinical trial, resulted in unprecedented improvement in the health status, and in reduced costs of related health care, for African-Americans with chronic heart failure by reducing mortality rates, reducing hospitalizations, and improving overall quality of life. Although the Food and Drug Administration approved BiDil in 2005, the use of BiDil in Black patients with chronic heart failure is still in single digits.

Dr. Ofili expressed particular concern about the daily obstacles that physicians face from drug benefit plans who continue to erroneously advocate for unproven therapies as substitutes for BiDil. "By ignoring the scientific evidenc
'/>"/>

SOURCE National Minority Quality Forum
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Betterment Of Health In Case Of Gay And Lesbian Civil Partnerships
2. Health Minister-Gujarat Rushed To Civil Hospital
3. Lack of Equipment and Skilled Doctors Costing Civilian Lives in Iraq
4. Pakistan civil servants may retire at 62
5. India-Born Dr Death Faces Civil Suits
6. Various Civil Society Groups Form Alliance to Fight HIV/AIDS
7. Doctors Ask MPs To Protect Human Rights By Banning Smoking In Enclosed Public Spaces
8. Equal Rights for HIV Infected Workers
9. Pfizer Acquires Worldwide Rights For New Overactive Bladder Drug
10. HIV Carriers Join Hands to Fight for their Rights
11. Need for Legal Rights to Birth Parents
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Lentigen Awarded Phase I SBIR Grant for Hepatitis C Vaccine 2Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America 2Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America 3Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America 4Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America 5Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 2Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 3Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 4Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 5WaferGen to Introduce New Service for Gene Expression Profiling Using the SmartChip 28TM 29 Real Time PCR System 6406 1WaferGen to Introduce New Service for Gene Expression Profiling Using the SmartChip 28TM 29 Real Time PCR System 6406 2WaferGen to Introduce New Service for Gene Expression Profiling Using the SmartChip 28TM 29 Real Time PCR System 6406 3WaferGen to Introduce New Service for Gene Expression Profiling Using the SmartChip 28TM 29 Real Time PCR System 6406 4Time to Blow Up the Pharmaceutical Sales Model 3F New Deloitte Debate 6403 1Time to Blow Up the Pharmaceutical Sales Model 3F New Deloitte Debate 6403 2Time to Blow Up the Pharmaceutical Sales Model 3F New Deloitte Debate 6403 3Caliper Life Sciences Partners with Prestwick Chemical to Offer Customized Chemistry and Biology Programs for Drug Discovery Research 6400 1Caliper Life Sciences Partners with Prestwick Chemical to Offer Customized Chemistry and Biology Programs for Drug Discovery Research 6400 2Caliper Life Sciences Partners with Prestwick Chemical to Offer Customized Chemistry and Biology Programs for Drug Discovery Research 6400 3